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Background. Most people around the world do not have access to facility-based diagnostic testing, and the gap in availability of 
diagnostic tests is a major public health challenge. Self-testing, self-sampling, and institutional testing outside conventional clinical 
settings are transforming infectious disease diagnostic testing in a wide range of low- and middle-income countries (LMICs). We 
examined the delivery models of infectious disease diagnostic testing outside clinics to assess the impact on test uptake and linkage 
to care.
Methods. We conducted a systematic review and meta-analysis, searching 6 databases and including original research manu-
scripts comparing testing outside clinics with conventional testing. The main outcomes were test uptake and linkage to care, delivery 
models, and adverse outcomes. Data from studies with similar interventions and outcomes within thematic areas of interest were 
pooled, and the quality of evidence was assessed using GRADE. This study was registered in PROSPERO (CRD42019140828).
We identified 10 386 de-duplicated citations, and 76 studies were included. Data from 18 studies were pooled in meta-analyses. 
Studies focused on HIV (48 studies), chlamydia (8 studies), and multiple diseases (20 studies). HIV self-testing increased test uptake 
compared with facility-based testing (9 studies: pooled odds ratio [OR], 2.59; 95% CI, 1.06–6.29; moderate quality). Self-sampling 
for sexually transmitted infections increased test uptake compared with facility-based testing (7 studies: pooled OR, 1.74; 95% 
CI, 0.97–3.12; moderate quality).
Conclusions. Testing outside of clinics increased test uptake without significant adverse outcomes. These testing approaches 
provide an opportunity to expand access and empower patients. Further implementation research, scale-up of effective service de-
livery models, and policies in LMIC settings are needed.
Keywords. decentralized, HIV, infectious diseases, self-collection, self-testing, STD
Infectious disease diagnostics are not available to large num-
bers of people around the world, especially in low- and middle-
income countries (LMICs) [1]. Diagnostic and screening tests 
are often confined to clinics with specialized laboratories [2–4]. 
Community clinics may not have the capacity to undertake di-
agnostic testing that requires special equipment and/or exten-
sively trained personnel to perform tests [4, 5]. Many people 
delay seeking care at centralized clinics because of stigma, com-
peting demands, and transportation problems [3, 6, 7].
Diagnostic services provided outside conventional settings 
could help to close this gap. Such services include self-testing, 
self-sampling, and institutional testing. Self-testing has an indi-
vidual collect their own specimen and interpret the test result 
[8]. Self-sampling has an individual collect their own spec-
imen but receive the result from a laboratory [9]. Institutional 
testing takes place in pharmacies, schools, correctional facil-
ities, or other settings [7, 10, 11]. These new approaches are 
transforming the field of diagnostic testing by expanding access 
to testing, empowering individuals, and creating innovative 
testing models [12].
Previous reviews have mostly focused on self-testing for HIV 
and self-sampling for sexually transmitted infections (STIs) 
[13–16]. In addition, studies have not examined how these 
different diagnostic approaches are shifting power away from 
centralized testing and toward the patients themselves. Self-
testing and self-sampling become particularly advantageous 
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in lockdown situations with restricted movement, as seen in 
the COVID-19 outbreak, where access to health care services 
and diagnostic testing become limited to medical emergencies. 
Testing outside of clinics gives greater agency to people and 
provides an opportunity to develop different service delivery 
models. The purpose of this study was to examine infectious 
disease diagnostic testing outside of clinics using a systematic 
review and meta-analysis.
METHODS
We conducted a systematic review and meta-analysis to iden-
tify new models applied to decentralized infectious disease 
testing. The systematic review was reported using the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) checklist (Supplementary File 1) and conducted fol-
lowing methodology described in the Cochrane handbook [17, 
18]. We developed a protocol for the review (Supplementary 
File 2), and it was registered in PROSPERO before commen-
cing the review (CRD42019140828).
Search Strategy
We searched 6 databases including PubMed, Embase, Scopus, 
Web of Science, Global Health, and CINAHL for relevant lit-
erature. Search terms were identified by health sciences librar-
ians from the University of North Carolina with experience in 
search algorithms. Search terms used in the databases included 
MeSH terms, keywords, and free text (Supplementary File 3). 
The search was conducted on July 10, 2019, and updated on 
August 8, 2019. Our search was not restricted by the year of 
publication or geographical location. We searched reference 
lists of articles included for additional citations.
Eligibility Criteria
Original research that compared testing outside of a clinic with 
a laboratory vs conventional testing in clinics was included. All 
eligible studies were in the English language and were focused 
on self-testing, self-sampling, and/or institutional testing for in-
fectious diseases. Studies that compared testing outcomes from 
interventions and conventional approaches regardless of study 
design were eligible for pooling. We included data from 14 
different infections/infectious diseases including HIV, human 
papillomavirus (HPV), hepatitis B, hepatitis C, syphilis, chla-
mydia, tuberculosis, gonorrhea, filariasis, trachoma, leprosy, 
dengue, visceral leishmaniasis, and influenza. We excluded sys-
tematic reviews, conference abstracts, and studies that lacked a 
comparator group.
Study Selection
Citations were uploaded into Endnote and de-duplicated. Six 
reviewers were assigned individual sections for title screening. 
Next, the 6 reviewers independently assessed the included ab-
stracts assigned to them for full-text reviews. Full-text studies 
were evaluated by 2 independent individuals for eligibility and 
inclusion. Studies with disagreements were sent to a third re-
viewer and discussed among the group, and a decision was 
reached to either include or exclude the study.
Data Extraction
We extracted data based on our prespecified outcomes of in-
terest. Data extracted included study design and location, 
testing site, type of test (self-testing, self-sampling), disease, 
sample size, linkage to care, test uptake, target population, 
test payment (out-of-pocket, paid for by research study, etc.), 
cost-effectiveness, and adverse outcomes reported. We defined 
linkage to care in HIV and all disease as any follow-up or con-
tact with health care professionals including treatment initia-
tion within 6 months of testing.
Quality Assessment for Included Studies
The quality of studies included for data pooling was assessed 
using the GRADE approach methodology [19]. For each study, 
we examined study limitations, risk of bias, consistency, preci-
sion, and other factors. The overall findings were assessed as 
high, moderate, low, or very low.
Analysis of Key Outcomes
Data from studies with the prespecified interventions of interest 
and outcomes with a comparator arm were pooled and analyzed. 
Studies that fit within thematic areas of interest, had a compar-
ator arm that evaluated out-of-clinic with laboratory testing vs 
conventional facility testing, and had complete data (on number 
of participants recruited and number of participants tested) for 
both comparator arms were eligible for inclusion in the meta-
analyses. Meta-analyses of prespecified groups were performed 
according to the different intervention approaches and out-
comes of interest, and unadjusted odds ratios were calculated 
using Review Manager 5.3. Heterogeneity was assessed with an 
I2 statistic [20]. We used a random-effects model in this study to 
ensure that variance was not underestimated.
RESULTS
The database search identified 21 344 citations, of which 10 958 
were nonduplicates. A total of 76 studies were included in the 
systematic review (Figure 1; Supplementary File 4). Of the 76 
studies, 18 studies were eligible for meta-analysis based on our 
thematic areas of interest and were pooled. The database search 
strategy identified 72 studies, and 4 additional studies were iden-
tified by hand searching of reference lists. We identified 46 ran-
domized controlled trials and 30 observational studies. Studies 
focused on HIV (48 studies), chlamydia (8 studies), gonorrhea 
(11 studies), syphilis (4 studies), HPV (2 studies), hepatitis (3 
studies), and tuberculosis (2 studies). Twenty studies focused 
on multiple diseases. Twenty-four studies included sexual mi-
norities, 13 studies included testers in remote locations, and 
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6 studies included first-time testers (Table 1). More than half 
(55%) of these studies were conducted in LMICs (n = 42), and 
45% (n = 34) were in high-income countries. We observed that 
testing outside of clinics created new delivery approaches, in-
creased test uptake, empowered testers, and had minimal risks.
HIV self-testing increased test uptake compared with 
facility-based testing (9 studies in 5 countries: pooled odds 
ratio [OR], 2.59; 95% CI, 1.06–6.29; I2  =  99%; n  =  33  912) 
(Table  2, Figure  2) [21–30]. The overall certainty of the ev-
idence was moderate (Supplementary File 5). Self-sampling 
for STIs (HIV, chlamydia, gonorrhea, hepatitis, and syphilis), 
which involved collecting body samples and submitting to 
a facility for testing, increased test uptake compared with 
facility-based diagnostic testing (7 studies in 5 countries: 
OR, 1.74; 95% CI, 0.97–3.12; I2 = 95%; n = 14 256; moderate-
quality evidence) (Figure  3) [31–35]. Testing outside clinics 
nonsignificantly increased access to diagnostic testing among 
sexual minorities and people in remote regions when com-
pared with testing in conventional settings (OR, 1.16; 95% CI, 
0.88–1.53; I2 = 93%; n = 2525) [35–41]. Four studies in LMICs 
reported a higher rate of testing in first-time testers among 
those who participated in testing models outside clinics 
21 344 studies identified through 
systematic search of  scientific 
databases
10 386 potentially eligible studies 
included for title screening
1995 abstracts included for 
screening
580 studies included for
full-text screening
4 additional studies included from 
hand searching of  reference lists
76 studies included for 
the final review
10 958 excluded after removing 
duplicates
8391 studies were excluded based 
on title not relevant to testing 
outside clinics
1415 abstracts excluded 
568 ineligible methods 
471 no intervention
254 noninfectious disease 
85 systematic reviews 
26 conference abstracts 
8 not English 
3 other reasons
508 full-text articles excluded 
225 had ineligible methods 
156 no clear comparator 
64 ineligible testing sites 
38 incomplete results and 
outcomes 
25 other reasons
42 assessed on self-testing 
13 had comparator arms
11 compared with standard testing
9 had appropriate data for pooling
included in meta-analysis
37 assessed self-sampling
14 had comparator arms
9 compared with standard testing
7 had appropriate data for pooling
included in meta-analysis
31 assessed digital interventions
17 had comparator arms
9 compared uptake with standard testing
3 had appropriate data for pooling
included in meta-analysis
Figure 1. Study selection.
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compared with conventional testing [21, 39, 42, 43]. Linkage 
to care was evaluated in 13 studies (Table 3), most of which 
were HIV-focused (10 studies, 8 in LMICs). The mean linkage 
to care rate for HIV within 6 months of testing was 17.3% in 
the testing-outside-of-clinics groups compared with 16.5% in 
the facility-based arms.
Testing outside of clinics gives power to all self-testers and 
self-sample testers (people receiving testing) about when, 
where, and how to test. One study showed that testing outside 
of clinics allowed for testing during the evenings, weekends, or 
holidays [44]. These approaches also allowed testers to test at 
home, at work, or at another location of their own choosing (3 
studies in 3 countries) [26, 35, 45]. Testing outside of clinics 
allowed testers to give test kits to friends (1 study in 1 country) 
[22] and refer a partner (spouses and/or sex partners; 7 studies 
in 4 countries) [21, 24, 30, 46–48].
Innovative test delivery services (through mail services, on-
line, pharmacies, schools, or correctional settings) improved 
test uptake compared with facility-based testing services. 
Fourteen studies that used local postal systems to mail an entire 
test kit (self-testing) or specimen collection kit (self-sampling) 
to the tester showed an increase in testing rates (OR, 1.41; 95% 
CI, 1.12–1.78; I2 = 92%; n = 1603) [33, 34, 36, 46, 49, 50]. Five 
studies in 4 countries used pharmacies to distribute test-based 
services (OR, 2.47; 95% CI, 1.85–3.30; I2 = 94%; n = 1393) [48, 
51–54]. Three studies in 2 countries used schools or other edu-
cational settings to distribute diagnostic services (OR, 1.19; 95% 
CI, 0.68–2.06; I2 = 92%; n = 203) [55–57]. Overall, 10 studies 
used digital interventions to enhance test uptake (Table 4). We 
Table 1. Characteristics of Studies Included in the Review
Characteristic No. of Studies
Self-testing 10 (7 LMICs; 3 HICs)
 HIV 10
 Other STIs 0
Self-sampling 6 (2 LMICs; 4 HICs)
 Non-HIV STIs 5
 Multiple STIs 1
Digital technology approach 6 (4 LMICs; 2 HICs)
 HIV 6
 Non-HIV 0
 Multiple STIs 0
Study design
 RCT 46 (26 LMICs; 20 HICs)
 Observational 30 (14 LMICs; 16 HICs)
Infectious disease
 HIV 48 (36 LMICs; 12 HICs)
 Chlamydia 8 (8 HICs)
 Multiple diseases 20 (6 LMICs; 14 HICs)
Population type
 Sexual minorities 24 (12 LMICs; 12 HICs)
 First-time testers 6 (4 LMICs; 2 HICs)
Abbreviations: LMICs, low- and middle-income countries; HICs, high-income countries; 
RCT, randomized controlled trial; STI, sexually transmitted infection. 
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defined digital as emails, websites, instant messaging, or related 
internet approaches. Seven studies found that digital interven-
tions increased the number of people who request diagnostic 
tests for infectious diseases compared with conventional ap-
proaches. Three additional studies evaluated the effect of dig-
ital interventions in improving STI self-sampling compared 
with conventional approaches, with a pooled OR of 3.50 (95% 
CI, 1.35–9.08; I2  =  99%; n  =  31 241; low quality of evidence) 
(Figure 4).
In terms of adverse outcomes, 3 studies examined the risks 
associated with testing outside of clinics. These articles reported 
on intimate partner violence, coercive testing, and depression 
and self-harm [24, 52, 58]. The rate of adverse events associ-
ated with testing outside clinics was found to be low (0.003% of 
participants in 2 studies), which was similar to adverse events 
in facility-based testing. Eight studies in 5 countries examined 
the cost associated with testing outside of clinics. Three out of 
4 studies assessing cost-effectiveness found that testing outside 
of clinics was cost-effective compared with facility-based ap-
proaches [59–61].
DISCUSSION
Our systematic review found that testing outside of clinics in-
creased diagnostic test access compared with conventional 
testing. The risks of adverse events associated with testing out-
side the facility compared with facility-based testing are min-
imal. HIV self-testing digital interventions increased diagnostic 
test uptake, and the linkage to care rate was similar compared 
with conventional approaches. This study expands the literature 
by summarizing the use of decentralized diagnostic testing for 
multiple infectious diseases, examining service delivery models 
not covered in previous reviews, and evaluating linkage to care 
for diagnostic testing outside conventional settings.
We found that STI self-sampling increased test uptake com-
pared with conventional testing approaches [31–35]. This is 
Study or Subgroup
Chanda1 2017
Chanda2 2017
Choko 2019
Gichangi 2018
Katz 2018
Kelvin 2018
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Mulubwa 2019
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1.13 [1.07, 1.19]
7.82 [4.34, 14.11]
1.63 [1.13, 2.36]
Total (95% CI)
Total events
Heterogeneity: τ2 = 2.20; χ2 = 744.86, df  = 10 (P < .00001); I 2 = 99%
Test for overall eect: Z = 2.10 (P = .04)
Facility-based testing
0.01 0.1 1 10 100
Self-testing
17 422 16 490 100.0% 2.59 [1.06, 6.29]
Events Events Weight M-H, Random, 95% CIM-H, Random, 95% CITotal Total
Self-Testing Facility-Based Testing Odds Ratio Odds Ratio
Figure 2. Self-testing compared with facility-based testing.
Cook 2007
Graseck
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Lippman 2007
Merchant 2018
Wood1
Wood2 2014
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305
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13.7%
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1.55 [1.02, 2.37]
2.64 [1.86, 3.73]
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Figure 3. Sexually transmitted infection self-sampling compared with facility-based testing.
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consistent with a global literature suggesting patient preference 
for self-sampling [62–64]. Self-sampling kits require minimal 
technical skills, may be cost-effective, and diversify testing lo-
cations [65, 66]. Self-sampling could enhance early detection of 
many STIs for which self-testing is not available [67, 68]. This 
approach could simplify and streamline the process of diag-
nostic testing [69].
We found that HIV self-testing digital interventions in-
creased testing rates compared with conventional approaches 
in 6 studies [25, 38, 43, 70–72]. This finding is consistent with 
earlier literature on promoting HIV self-testing [33, 73] but to 
our knowledge has not been the focus of previous systematic 
review findings. This finding is consistent with earlier studies 
that report that advertising free HIV self-testing kits on dating 
websites, mobile phone apps, and social media platforms helped 
to reach more men who have sex with men (MSM). This also 
simplified and increased access to many first-time testers when 
compared with testing in conventional health facilities [74–76]. 
Although digital interventions may be preferred by some key 
populations, this approach relies on self-reporting results, 
which may reduce the validity of the findings [77, 78]. However, 
external validation can be obtained through built-in interpre-
tation programs to reduce bias due to self-reporting of test re-
sults. It is therefore important for digital self-testing strategies 
and models to incorporate linkage-to-care services such as 
real-time online supervised testing, digital tracking of test kit 
utilization, and provider-initiated follow-up calls or other inter-
ventions [21, 79, 80].
We observed a similar rate of linkage to HIV care after testing 
outside of clinics compared with conventional facility-based 
testing. This finding may be a result of who chooses to test outside 
of clinics and is similar to an observation made in a Copenhagen 
study [81], but has not been the focus of systematic reviews. 
Although other research has shown lower linkage to HIV care 
following self-testing [23, 29, 39, 82], recent studies suggest 
that embedding HIV self-testing with health provider–initiated 
Table 3. Studies Reporting Linkage to Care in Diagnostic Testing Outside Clinics
Study Location Target Population Disease
% Linked to Care  
(Intervention vs Control Group)
Linkage to Care 
Time Point
MacPherson et al. 2014 [29] Malawi Adults HIV 2.2% vs 0.7% 6 mo 
Morano et al. 2014 [84] USA General population HCV 93.8% vs 18.2% 1 mo
Parker et al. 2015 [85] Swaziland General population HIV 34.0% vs N/A 6 mo
Kelvin et al. 2019 [43] Kenya Female sex workers HIV 14.0% vs 9.3% 2 mo
Chanda et al. 2017 [52] Zambia Female sex workers HIV 51.9% vs 61.1% 4 mo
Reddy et al. 2016 [73] USA MSM HIV 73% vs N/A 6 mo
Meehan et al. 2017 [61] USA University students Chlamydia 74% vs 50% Not stated 
Miller et al. 2017 [82] France Young adults  
(aged 17–24 y)
HIV 85.1% vs 35.1% Not stated 
Barnabas et al. 2016 [70] S/A Uganda Men  
(aged 16–49 y)
HIV 74% vs 66% 9 mo
Ortblad et al. 2017 [23] Uganda Female sex workers HIV 8.3% vs 8.2% 4 mo
Choko et al. 2019 [21] Malawi Pregnant women HIV 10% vs 4% 1 mo 
Green et al. 2018 [39] Vietnam MSM HIV 81% vs 69.1% Not stated 
Johnston et al. 2018 [86] Canada General population HIV 63.2% vs 29.3% Not stated 
Abbreviation: MSM, men who have sex with men.
Table 4. Use of Digital Technology Across the Testing Continuum
Digital Technology Across the Testing Continuum
Digital Technology
Promote Testing  
(Demand Generation)
Focus Testing Services  
(who Should Be Tested)
Order and Receive 
Self-Testing or  
Self-Sampling Kit
Results Notification/ 
Instructions and Counseling 
Websites, email Katz 2018 [25]  
Kersaudy-Rahib 2017 [33]  
Jenkins 2012 [55]
Jenkins 2012 [55] Jenkins 2012 [55] Wang 2018 [71]
Social media Katz 2018 [25]    
Mobile apps Wray 2018 [38]  
Zhu 2019 [72]
   
Text messages Barnabas 2016 [70]  
Kelvin 2018 [26]  
Kelvin 2019 [43]
Kelvin 2018 [26]  
Kelvin 2019 [43]
 Barnabas 2016 [70]
Remote monitoring sensors Wray 2018 [38]   Wray 2018 [38]
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follow-up can enhance linkage to care [83]. There is still a need 
to improve linkage to HIV care after self-testing.
Our study has several important implications. From the 
policy viewpoint, this work demonstrates that the use of dig-
ital technology in testing outside clinics is a useful strategy for 
improving infectious diseases screening and linkage to care, 
and policies that aim to promote the use of these strategies are 
needed. These models may be especially useful for diseases as-
sociated with stigmatization such as HIV and other STIs, but 
many studies focus on HIV. Also, testing outside clinics will be a 
key strategy for continued testing in future pandemic situations 
where lockdowns and restricted movements are implemented. 
There is a need for more studies on the implementation of these 
strategies for other infectious diseases apart from STIs. Second, 
from the research perspective, we found that studies that aimed 
to evaluate the cost-effectiveness of decentralized diagnostic 
testing are limited, with most of these focusing on HIV infec-
tion alone. Future studies are needed to evaluate the cost-effec-
tiveness, barriers, and facilitators of these approaches.
This study also has some limitations. First, very few studies 
have examined the risks and adverse outcomes associated with 
testing outside of clinics [24, 52, 58]. Further post-trial research 
is needed to fully understand the risks associated with testing 
outside of clinics. Second, none of the included studies provided 
testing to persons living with disabilities. This is another op-
portunity for expanding the impact of testing outside of clinics. 
Third, the number of studies for each outcome included in this 
study was low, and we noted that substantial heterogeneity 
across studies exists. Fourth, we only pooled the unadjusted re-
sults of the included studies, which may make the results biased. 
However, in most included studies, the participants in the con-
ventional service group and the decentralized diagnostic testing 
group were reported to be comparable. Additionally, for studies 
that had multiple intervention arms compared with 1 control 
group, variance may have been underestimated.
CONCLUSIONS
Testing outside of clinics provides an opportunity to expand ac-
cess to diagnostic testing for infectious diseases and give power 
to testers through innovative delivery models. Testing outside 
of clinics can reach the last mile of many health systems, driving 
access for hard-to-reach groups in diverse LMIC settings. The 
modest evidence on adverse events suggests that these occur 
at a similar rate in facility-based testing. Further implementa-
tion research and scale-up of effective decentralized models in 
LMIC settings are needed.
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